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Abstract
Background: To improve quality of care for patients with hip and knee osteoarthritis (OA), general practitioners
(GPs) and physiotherapists (PTs) in a Norwegian municipality initiated an intervention. The intervention aimed to
increase provision of core OA treatment (information, exercise, and weight control) prior to referral for surgery,
rational use of imaging for assessing OA and improve communication between healthcare professionals. This study
assessed the effectiveness of this intervention.
Methods: Forty-eight PTs and one hundred one GPs were invited to the intervention that included two interactive
workshops outlining best practice and an accompanying template for PT discharge reports. Using interrupted time
series research design, the study period was divided into three: pre-implementation, transition (implementation)
and post-implementation. Comparing the change between pre- and post-implementation, the primary outcome
was patient-reported quality of OA care measured with the OsteoArthritis Quality Indicator questionnaire. Secondary
outcomes were number of PT discharge reports, information included in GP referral letters to orthopaedic surgeon,
the proportion of GP referral letters indicating use of core treatment, and the use of imaging within OA assessment.
Analyses involved linear mixed and logistic regression models.
Results: The PT workshop had 30 attendees, and 31 PTs and 33 GPs attended the multidisciplinary workshop. Two hundred
eight and one hundred twenty-five patients completed the questionnaire during pre- and post-implementation, respectively.
The adjusted model showed a small, statistically non-significant, increase in mean total score for quality of OA care (mean
change = 4.96, 95% CI -0.18, 10.12, p:0.057), which was mainly related to items on OA core treatment. Patients had higher
odds of reporting receipt of information on treatment alternatives (odds ratio (OR) 1.9, 95% CI 1.08, 3.24) and on self-
management (OR 2.4, 95% CI 1.33, 4.32) in the post-implementation phase. There was a small, statistically non-significant,
increase in the proportion of GP referral letters indicating prior use of core treatment modalities. There were negligible
changes in the number of PT discharge reports, in the information included in the GP referral letters, and in the use of
imaging for OA assessment.
Conclusion: This study suggests that a primary care intervention including two inter-active workshops can shift the quality
of care towards best practice recommendations.
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Background
Osteoarthritis (OA) is a serious joint disease characterized
by pain, disability, and impaired quality of life. Prevalence
of OA increases with age, and nearly one in two people
will develop symptomatic knee OA and one in four symp-
tomatic hip OA in their lifetime [1, 2]. With an aging
population and the epidemic of obesity, the prevalence of
OA is set to rise [3]. OA is one of the leading causes of
pain and disability for the adult population worldwide [4]
and one of the major contributors to years lived with dis-
ability [5]. The costs of treatment and work-related losses
represent a considerable economic burden [6, 7].
Recommended first-line, core treatments include pa-
tient education, self-management, exercise, and weight
reduction [4, 8–10]. These core interventions can reduce
pain and improve function and should be offered to all
individuals with symptomatic OA. Joint replacement of-
fers an effective option for those with pain and reduced
function that has a substantial impact on their quality of
life and are refractory to non-surgical treatment [11].
However, it is costly and associated with medical and
surgical risks [12–15], and although most patients bene-
fit greatly from the operation [16–18], it is not always ef-
fective [19]. One in ten hip and one in five knee joint
replacements have painful joints postoperatively [20].
Due to the increasing prevalence of OA, the demand for
joint replacements is expected to accelerate and quadru-
ple by 2030 [21]. Since it is estimated that only 12–53%
of patients with symptomatic OA should be offered
arthroplasties [22], it is important to improve the uptake
of high-quality non-surgical care. In addition, previous
research has suggested an overuse of resource intensive
Magnetic Resonance Imaging (MRI) in the diagnosis and
treatment of moderate to severe OA [23]. Since deci-
sions on joint replacement can be made using the less
resource intensive conventional radiographs, and use of
Magnetic Resonance Imaging (MRI) is usually unneces-
sary [24], this resource overuse should be addressed.
Evidence based recommendations and standards of care
for OA management have existed, and remained consist-
ent, for over a decade [4, 8–10], but provided care often
does not align well with recommended treatment modal-
ities [25–27]. This is particularly evident for the core treat-
ments. Among physiotherapists’ (PTs) practice, exercise
treatment is frequently provided, but PTs also tend to pro-
vide several other treatment modalities with no evidence
or moderate to low quality of evidence (e.g., acupuncture,
electrotherapy) [28–31]. In order to provide best value
OA care, it is important to both implement evidence
based cost-effective care and reduce the use of care with
no or limited evidence and at the same time rationalize re-
source use (e.g., use group-based treatments). Previous re-
search indicate that both general practitioners (GPs) and
PTs are reluctant to discuss weight issues with their pa-
tients [32–34]. It has also been shown that GPs favoured
monitoring patients’ physical function, pain and analgesia
use over body mass index (BMI), self- management plans
and exercise advice [35]. Indeed, some GPs feel they have
insufficient expertise to advise patients about exercise
[36]. Further, few Norwegian PTs send discharge reports
routinely [37], which may limit the GPs’ knowledge on ef-
fects of physical therapy and restrain the communication
between health professionals.
A small number of best practice initiatives to improve
quality of OA care have been conducted with diverging
results [38–44]. The current study, the STavanger osteo-
ARThritis (START) study, was initiated by a group of
clinicians (GP, PT, and orthopaedic surgeon) working in
primary and specialist healthcare services. The purpose
of START was to employ an intervention to increase the
communication between GPs and PTs, to improve the
quality of OA care by implementing evidence-based
treatment recommendations for OA care, and to evalu-
ate the impact of the intervention on: 1) alignment of
care with guideline recommendations, 2) frequency of
PTs providing discharge reports to the GPs through
provision of a template for discharge report, 3) fre-
quency of GP referral letters to orthopaedic surgeons in-
cluding pre-defined relevant information, 4) frequency
of GP referral letters indicating prior use of core treat-
ment, and 5) frequency of GP referral letters indicating
that the patient had an MRI taken, and not a conven-




The START study, undertaken between September 2016
and November 2017, employed an interrupted time
series design, which is considered to be the strongest
quasi-experimental research design [45]. The study was
conducted in Stavanger Municipality, Norway, which has
a population of approximately 130,000 inhabitants. It
represents a collaborative study between GPs and PTs in
Stavanger primary healthcare, an orthopaedic surgeon at
the Department of orthopaedics at Stavanger University
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Hospital, and researchers at National Advisory Unit on
Rehabilitation in Rheumatology at Diakonhjemmet
Hospital, Oslo. The START study was prospectively reg-
istered at clinicaltrials.gov (NCT02876120) and is re-
ported according to the TREND checklist [46]. The
START study was linked to the “Joint Implementation
of Guidelines for oSteoArthritis in Western Europe”
(JIGSAW-E) implementation approach (https://jigsaw-e.
com/) which was based upon the MOSAICS study [47]
where implementation science and knowledge mobilisa-
tion theory (e.g. Normalisation Process Theory, imple-
mentation theory, the Theoretical Domains Framework
and principles of adult learning) was used to guide
implementation.
The START study was divided into three periods: pre-
implementation, transition (implementation) and post-
implementation period (Fig. 1). The data collection took
place during pre- and post-implementation periods, with
each lasting 8 weeks. The intervention was implemented
during the transition period, which lasted 44 weeks. The
transition period was planned to be long to give the
healthcare professionals time to implement the interven-
tion and change their practice. This way, the data collec-
tion in the pre- and post-implementation periods took
place at the same time of the year (autumn).
The Regional Committee for Medical and Health Re-
search Ethics (Ref. no.: 2016/1734 REK South-East D)
and The Data Inspectorate/ Data Protection Official at
Stavanger University Hospital (Ref. no.: 2016/31) ap-
proved the study.
Participants
All GPs and PTs working in private practice in Stavan-
ger Municipality who saw adults with OA were invited
to participate in the study. The GPs received a written
invitation from the Stavanger Municipality Chief Med-
ical Officer to attend a multidisciplinary workshop. Two
of the PTs in the project group visited all PT clinics and
invited the PTs to attend the PT workshop and the
multidisciplinary workshop. Patient participants were re-
cruited by the PTs during the pre- and the post-
implementation periods. The pre- and the post-
implementation participants were different patients. All
patients that had received physiotherapy treatment for at
least 2 weeks (4–6 sessions) due to symptomatic hip
and/or knee OA fulfilled the inclusion criterion. All pa-
tients with language- or other impairments disqualifying
completion of patient-reported quality of OA care ques-
tionnaire were excluded.
Blinding
The GPs, PTs and patient participants were informed on
the purpose of the study, but they remained blinded re-
garding the study outcome measures.
Intervention
The intervention intended to facilitate communication
between health professionals in primary healthcare and
with healthcare professionals in specialist healthcare to
ensure that people with hip and knee OA would experi-
ence timely, well integrated, and high-quality OA care
(Fig. 2). The intervention included a PT workshop and a
multidisciplinary workshop and was linked to the
JIGSAW-E project (https://jigsaw-e.com/) and inspired
by the SAMBA study [48] . The aim of JIGSAW-E was
the implementation of an approach to improve the qual-
ity of care and to support self-management of OA in pri-
mary care. The JIGSAW-E approach includes four
innovations: 1) an OA guidebook written by patients
and health professionals, 2) a model consultation for
diagnostic and follow-up consultations, 3) training for
health professionals delivering the care, and 4) quality
indicator recording and measurement tools. The
SAMBA study intervention included a PT workshop and
a multidisciplinary workshop to implement a model for
structured OA care in primary health care. Compared to
the JIGSAW-E and the SAMBA interventions, the STAR
T study included some new elements: distribution of a
Fig. 1 Study timeline
Østerås et al. BMC Musculoskeletal Disorders           (2021) 22:79 Page 3 of 14
template for PT discharge reports and a discussion on
indications for joint replacement, and a focus on the
content of GP referral letters to orthopaedic surgeons.
The PT workshop
To learn about current OA treatment recommendations,
eligible PTs were encouraged to attend the PT workshop
arranged in Stavanger on the 26th of October 2016. The
workshop included a one-day (9 h) OA educational
programme organised by the “Active with osteoArthritis”
(ActiveA) management programme [36], which builds
on similar Swedish [41] and Danish [42] programmes.
The workshop included an update on OA epidemiology,
clinical features, and treatment recommendations. Edu-
cation in delivery of a patient OA education programme,
individually tailored semi-standardised exercises, per-
formance testing, and healthy eating and weight reduc-
tion strategies was given. The PTs received access to the
ready-to-use patient OA education programme (Power-
Point file and manuscript) and access to a database with
recommendations for resistance exercises and dose
specifications. As part of the ActiveA management
programme, the PTs were encouraged to regularly ar-
range group-based 3 h patient OA education pro-
grammes followed by a 6 weeks exercise programme
with twice weekly 1-h supervised group sessions (For
more details, see Østerås et al. [49]).
The multidisciplinary workshop
The local project group (AP, HW, IBB and TH)
arranged one multidisciplinary workshop in each of the
six town districts. The separation by districts was done
purposely to facilitate communication between GPs and
PTs working in the neighbourhood. The second purpose
of the workshop was to present current recommenda-
tions for OA treatment. The 1.5-h multidisciplinary
workshop took place after work hours during November
and December 2016, which was at the start of the transi-
tion period. It included an update on current treatment
recommendations for OA care and a presentation of the
PT-led patient OA education and exercise programme
(the ActiveA programme). An orthopaedic surgeon pre-
sented views on when to consider referral to secondary
care, relevant information to include in the GP referral
letter, and recommendations for the use of imaging mo-
dalities for decision making about joint replacement sur-
gery. Towards the end of the workshop, the local project
group facilitated a multidisciplinary discussion regarding
OA management.
Development of a PT discharge report template
Research on barriers or facilitators for writing discharge
reports are lacking, but the project group hypothesized
that time could be a limiting factor and that PTs’ uncer-
tainty regarding appropriate content and quantity could
represent barriers. To standardize the content and po-
tentially reduce the time needed for PTs to write dis-
charge reports, a template for OA discharge reports was
developed by the project group and distributed to the
PTs. The one-paged template included the following
items: patient characteristics, treatment period, pre-
treatment assessment (4–5 lines), treatment goal, treat-
ment effect conclusions (3–4 lines), and post-treatment
assessment (including pain level at activity/rest/night, re-
stricted joint range of motion, muscle strength, joint sta-
bility, physical function, walking ability and walking aids,
physical performance tests, OA-specific patient reported
outcomes, work participation, smoking and body
weight/body mass index).
Data collection
The data collection took place during two periods of 8
weeks: the pre-implementation period on September 19th
-November 6th in 2016 and the post-implementation
period on September 18th -November 5th in 2017.
The patient participants self-reported on an anonym-
ous two-paged paper questionnaire handed out by the
PTs after a treatment session and put it in a sealed
Fig. 2 Overview of the intervention components
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envelope before leaving the clinic. The questionnaire in-
cluded the following items: age, sex, OA joint location
(hip/knee, uni. vs. bilateral), joint prosthesis in hip/knee
(yes/no; uni. vs. bilateral), pain level (Likert scale, five
levels), physical function (Likert scale, five levels) and
patient-reported quality of OA care (quality indicators
(QIs), 16 items).
Number of discharge reports to referring GPs was ex-
tracted from the Norwegian Health Economics Adminis-
tration (Helfo), which is the Directorate of Health’s
external agency responsible for making payments from
the National Insurance scheme to healthcare providers,
suppliers and service providers, as well as individual re-
funds of expenses.GP referral letters were extracted from
the Stavanger University Hospital’s register.
Primary outcome
The primary outcome was change in patient-reported
quality of OA care from pre- to post-implementation
period. It was measured with the OsteoArthritis Quality
Indicator questionnaire version 2 (OA-QI v2) (Add-
itional file 1) [50]. OA-QI v1 was developed in 2010
based on published QIs for OA care identified in a lit-
erature search and was refined using expert panels and
patient interviews [51]. A minor revision was undertaken
in 2015 [50]. OA-QI v2 reflects current OA care guide-
line recommendations [4, 8–10] and includes 16 QI
items related to patient OA education and information,
regular provider assessments, referrals, and pharmaco-
logical treatment. Previous applications of the question-
naire have showed acceptable measurement properties
including reliability, validity, responsiveness, and inter-
pretability [50, 51]. OA-QI v1 has been previously tested
in UK primary care in a cluster-randomised trial and has
been shown to be responsive to the use of national rec-
ommendations for OA care [43].
An example of an item with response alternatives is as
follows: ‘Have you been given information about osteo-
arthritis from a health professional? Yes/No/Don’t re-
member’. Each QI item was considered passed if the
patient had checked ‘Yes’ and was considered ‘eligible’ if
the patient responded ‘Yes’ or ‘No’ for that item. On the
patient level, the QI pass rate was calculated as the total
number of items passed divided by the number of eli-
gible items for each patient (in percentage), ranging
from 0 to 100, with 100 representing the best quality of




The number of Stavanger PTs’ registered discharge re-
ports to referring GPs was extracted from the Helfo
register. The content could not be accessed, but the
number of discharge reports was seen as a quality indi-
cator given the low level of reports in traditional care.
Information in GP referral letters
Stavanger GPs’ referral letters to the Department of
Orthopaedic Surgery at Stavanger University Hospital
during pre- and post-implementation periods were anon-
ymized by a secretary outside the project group. Referrals
related to acute conditions (e.g., ligament ruptures, infec-
tions), hip impingement conditions or post-operative re-
view were excluded. The project group discussed and
agreed beforehand on a list of 31 items that they consid-
ered relevant to be included in GP referral letters. The list
was based on current guideline recommendations (e.g.,
that core treatment should be provided prior to surgery)
and other information that the orthopaedic surgeons need
for their evaluation of whether the patient is a candidate
for arthroplasty. Two of these items (medication list and
comorbidity) are normally automatically included in the
electronic referral. Inclusion of information in the anon-
ymized referral letters was scored (included vs. not in-
cluded) by the first author.
Core treatment
The proportions of people with OA that, according to the
GP referral letter, had used one or more of the core treat-
ment modalities (physiotherapy, supervised exercise,
weight reduction, OA information and/or OA education
programme) prior to orthopaedic referral, were calculated.
Use of imaging for OA assessment
The proportion of people that, according to the GP re-
ferral letter, had been assessed using an MRI for decision
making on joint replacement surgery, but not a conven-
tional radiograph, were calculated. Those with no use of
imaging were ignored.
Deviation from the protocol (clinicaltrials.gov:
NCT02876120): We were unable to assess the proportion of
people with OA referred to orthopaedic surgeon in second-
ary care that underwent scheduled joint surgery. This was
due to not being able to determine relevant patient cases
within the hospital’s ICT system.
Statistical analyses
The patient samples represent convenience samples. A
time series-repeated observations of outcome measure-
ments was collected during the pre- and post-
implementation with the 8 + 8 weeks representing 16
time points. Linear mixed models showed no slopes
within the pre- or the post-implementation period. It
was therefore decided to pool data for the 8 time points
during the pre- and the 8 time points in the post-
implementation period. A linear multi-level mixed
models with random intercepts was fitted to adjust for
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the effect of clustering (PT clinic). There were 1–7 PTs
working in each PT clinic. Since the intraclass correl-
ation coefficient (ICC) was very low (< 0.001) and single-
level and multi-level analyses gave similar results, a
multilevel model was considered unnecessary. Hence,
the primary outcome was assessed applying a single-
level model with a before-after design to evaluate level
changes from the pre-implementation period to the
post-implementation period. The final regression model
was adjusted for patients’ age and sex. Individual OA-
QI v2 items were analyzed applying logistic regression
crude models and the models were adjusted for pa-
tients’ age and sex.
The proportions of referral letters with vs. without
relevant information on each of the 31 predefined items
were assessed with unadjusted logistic regression
models, or with unadjusted logistic regression with the
Firth procedure for bias reduction in rare events. To ac-
count for multiple analyses testing, a Bonferroni correc-
tion of the p-value was done (p = 0.0016). A randomized
subsample (20%) of the GP referral letters was re-scored
by a co-author (AP), and the two sets of scores were
compared. Inter-rater reliability for the two raters (NØ
and AP) was examined by calculation of perfect agree-
ment and kappa. Statistical analyses were performed
using STATA/IC 14.
Patient and public involvement and engagement
Two patient research partners were involved during
study planning and in development of study materials
(including the questionnaire and patient information).
Using the GRIPP2 reporting checklist [52], a summary
of the patient and public involvement and engagement
in the study is presented in the Additional file 2.
Results
In 2016, 101 GPs and 48 PTs in private practice in
Stavanger were eligible for the START study. Thirty PTs
in Stavanger attended the ActiveA workshop in October
2016. Another 10 PTs had previously attended an Acti-
veA workshop (prior to the transition period), and one
PT clinic (involving 2 PTs) had started providing OA
education and exercise programme to their patients
prior to the transition period. Thirty-one (65%) of the
PTs and 33 (33%) of the GPs attended the multidiscip-
linary workshop. In total 13 of the 15 eligible PT clinics
and 22 of the 31 GP practices within Stavanger were
represented at the workshop.
During the pre-implementation period, 208 patient
participants were recruited from 13 PT clinics, and 125
patient participants from 11 PT clinics were recruited
during the post-implementation period (Table 1). The
number of patients per clinic ranged from one to 57
during pre-implementation and two to 30 during post-
implementation periods. The patient participants’ mean
age was 63 years at pre- and 65 years at post-
implementation, and females accounted for 72 and 65%
of the two samples, respectively. Patients’ characteristics
are provided in Table 1.
The hospital received 104 GP referral letters for as-
sessment by an orthopaedic surgeon during the pre-
implementation period, 86 of these were included in this
evaluation and 18 were excluded (not OA-related condi-
tion n = 7, post-operative review n = 6, acute condition
n = 5). For the post-implementation period, the hospital
received 114 referral letters, of which 103 were included
and 11 were excluded (acute condition n = 6, not OA-
related condition n = 2, hip impingement n = 1, post-
operative review n = 1, referred by hospital doctor n = 1).
Primary outcome
The OA-QI v2 mean (SD) total pass rate increased from
62.4 (23.6) to 67.7 (21.2) from pre-to post-implementation
period (mean difference 5.3; 95% confidence interval (CI)









Sex, female, n (%) 150 (72) 81 (65)
Age, mean (SD) 63 (10) 65 (10)
Osteoarthritis joint location, n (%)
Hip/hips 48 (24) 33 (27)
Knee/knees 75 (37) 47 (39)
Hip and knee and/or
multisite
81 (40) 42 (34)
Hip or knee joint prosthesis, n (%)
No joint prosthesis 157 (75) 92 (74)
One joint 35 (17) 25 (20)
Two or more joints 16 (8) 8 (6)
Pain, n (%)
No pain 1 (0.5) 4 (3)
Very mild pain 18 (9) 13 (10)
Mild pain 44 (21) 22 (18)
Moderate pain 112 (54) 71 (57)
Severe pain 28 (14) 15 (12)
Self-reported function, n (%)
Very good function 3 (1) 2 (2)
Good function 57 (27) 36 (29)
Neither good nor poor
function
67 (32) 47 (38)
Poor function 70 (34) 32 (26)
Very poor function 6 (3) 8 (6)
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0.31, 10.35; p = 0.037) as illustrated in Fig. 3. When ad-
justed for patient age and sex, the difference became sta-
tistically non-significant (mean difference 4.96; 95% CI
-0.18, 10.12; p = 0.057). Figure 4 illustrates that there was
no slope during any of the periods, but that there was a
small level change from the pre- to post-implementation
period.
Individual QI item pass rates are provided in Table 2.
Figure 5 illustrates the differences in item pass rates dur-
ing pre- and post-implementation periods. Eight individ-
ual item pass rates increased from pre- to post-
implementation by 3–12 percentage points, four were
mainly unchanged and four showed a reduction in pass
rates by 4–14 percentage points. The pass rates in-
creased for all five items on information: about the OA
disease, treatment alternatives, self-management, im-
portance of physical activity and on potential effects and
side effects of anti-inflammatory medication. The patient
participants had significantly higher odds during post-
implementation for having received information on dif-
ferent treatment alternatives (Odds ratio (OR) 1.9; 95%
CI 1.08, 3.24; p = 0.024) and on self-management (OR
2.4; 95% CI 1.33, 4.32; p = 0.003) compared to during
pre-implementation. Higher pass rates post- compared
to pre-implementation were seen for most of items
reflecting recommended core treatment, but not for the
two items regarding weight management, for which the
pass rate was unchanged or slightly reduced.
Secondary outcomes
PT discharge reports
Both the total number of discharge reports and number
of PTs writing discharge reports showed a small increase
from pre- to post-implementation. The number of regis-
tered PT discharge reports was 149 (registered by 24
PTs) during the pre- and 158 (registered by 30 PTs) dur-
ing the post-implementation period. The mean (min-
max) discharge reports per PT was 6 (1–27) during pre-
and 6 (1–21) during post-implementation.
Information in GP referral letters
Overall, only minor changes in the information included
in GP referral letters were observed from pre- to post-
implementation period (Table 3). However, there was a
clear increase in the proportion of referral letters that in-
cluded information on duration of pain symptoms and
smoking cessation from pre- to post-implementation
(Table 3).
Core treatment
According to the GP referral letters, there was a small,
but statistically non-significant, increase in the propor-
tion of people with OA that had exploited the core treat-
ment modalities before being referred to orthopaedic
surgeon (31% vs. 34%, OR 1.2; 95% CI 0.61, 2.07; p =
0.706). The proportion of referral letters including infor-
mation on prior use of physiotherapy increased from 22
to 31%, but the difference in odds did not reach statis-
tical significance (OR 1.2; 95% CI 0.65, 2.33; p = 0.515).
MRI and conventional radiographs for OA assessment
The proportions that had taken an MRI for OA assess-
ment were 47% (n = 40) during pre- and 49% (n = 50)
during post-implementation period. Among these, the
proportions that had only taken MRI, and not conven-
tional radiographs, were similar during the pre- and
post-implementation periods: 63% (25/40) vs. 64% (32/
50), respectively.
Inter-rater reliability
On the referral level, the inter-rater reliability was accept-
able with a perfect agreement mean score of 94% (min-
max: 84–100%). On the single item level, inter-rater reli-
ability was acceptable with a perfect agreement mean
score of 96% (min-max: 68–100%). The item ‘Information
on pain level included’ showed the lowest agreement,
since one rater scored ‘Yes’ and the other rater scored ‘No’
on six (32%) of the 19 referral letters. For all other items,
the agreement was very high. The mean kappa was 0.77
with values ranging from 0.44 to 1.00.
Discussion
The START study showed that after implementing
international guidelines for OA care among PTs and
GPs in primary healthcare, OA management indicated a
non-significant, small shift towards improved alignment
with international recommendations. The improvement
was mainly related to core treatment modalities and was
in particular evident for provision of information on OA
treatment alternatives and on self-management. This
was supported by a small, statistically non-significant
increase in the proportion of GP referral letters to ortho-
paedic surgeons indicating that core treatment modal-
ities had been previously used. However, patient-
reported receipt of advice about weight management did
not improve, and there were negligible to no changes re-
lated to PT discharge reports, information in GP referral
letters, and the use of different imaging modalities for
OA assessment.
The patient sample characteristics in this and previous
studies [31, 48–51, 53–55] were comparable on age, sex
and OA location, but the START study included a
higher proportion of patient participants with joint pros-
thesis as compared with a previous implementation
study [49]). The mean total pass rate for the pre-
implementation period in the START study was much
higher compared to other studies that have used the
OA-QI questionnaire [31, 48–51, 53–55]. The high pre-
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implementation score in the START study may be re-
lated to differences in patient recruitment since this
study recruited patient participants that had received 4–
6 physiotherapy treatment sessions. This in contrast to
the previous studies, in which patients were recruited
from the general population [51, 55], GP practices [49,
53], at first session of physiotherapy [49], scheduled for
a consultation with an orthopaedic surgeon [31], or
among members of a patient organisation [54, 55]. In
addition, 10 physiotherapists in this study had attended
an ActiveA workshop prior to the transition phase, and
1 clinic had started providing OA education and exercise
programme to their patients. This may also potentially
have contributed to the high pre-implementation pass
rate in the START study.
The 5 percentage points increase in mean total pass
rate from the pre- to post-implementation period in the
START study indicates that the provided care became
somewhat more in line with the guideline recommenda-
tions. This finding was supported by the small increase
Fig. 4 Patient-reported quality of osteoarthritis care. Marginsplot of total mean score during 8 pre-implementation weeks in 2016 (n = 208 patient
responders) and 8 post-implementation weeks in 2017 (n = 125 patient responders)
Fig. 3 Patient-reported quality of osteoarthritis care. Boxplot of total mean score during the pre-implementation in 2016 (n = 208 patient
responders) and the post-implementation in 2017 (n = 125 patient responders)
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in the proportion of GP referral letters indicating that
core treatment had been exploited before surgical treat-
ment options were considered. In the SAMBA study, a
similar OA guideline implementation study, the mean
total pass rate in the intervention group increased from
39% at baseline to 60% at the six-month follow-up [49].
Hence, the pre-implementation pass rate in the START
study (62%) was higher than the post-implementation
pass rate in the SAMBA study, which leaves a smaller
scope of improvement in the START study. While the
5-point increase was higher than the previously reported
measurement error of 3 for this instrument [50], the im-
portance of a 5-point increase on the OA-QI question-
naire may be debated.
For individual OA-QI items post-implementation pass
rates of 79–96% were seen for most core treatment
items. These pass rates are comparable to the post-
implementation rates for the intervention group in the
SAMBA study [49] but are much higher than the pass
rates in the observational studies [31, 48, 50, 51, 53–55].
This demonstrates the potential of judicious implemen-
tation studies in making OA management more in line
with international treatment recommendations. How-
ever, the post-implementation pass rates for weight loss
advice and for referrals to support for losing weight
remained low in the START study as in the SAMBA
study [49]. Also, observational studies have revealed low
pass rates for weight management uncovering a large
scope for improvement [31, 51, 53–55]. The low pass
rates may be related to health professionals’ barriers to-
wards discussing weight issues and their prioritizing to
review other aspects of health [32, 33, 35]. Further, there
are relatively few weight loss services in Norway that the
GP can refer to, and the GPs may not be aware of those.
Table 2 Patient-reported quality of osteoarthritis care: individual item pass rates and odds ratio for item achievement













Information about OA from a HP
(n = 308c)
84 89 ↑5 1.7 (0.83, 3.40) 0.152 1.8 (0.86, 3.60) 0.124
Information about different
treatment alternatives (n = 308)
67 79 ↑12 1.9 (1.08, 3.24) 0.024 1.8 (1.04, 3.14) 0.037
Information on self-management
(n = 308)
69 84 ↑15 2.4 (1.33, 4.32) 0.003 2.6 (1.43, 4.79) 0.002
Information about importance of
physical activity (n = 328)
91 96 ↑5 2.2 (0.81, 6.19) 0.120 2.3 (0.83, 6.47) 0.108
Referred to HP for physical
ctivity/exercise (n = 316)
87 90 ↑3 1.4 (0.68, 2.93) 0.344 1.4 (0.66, 2.86) 0.406
Advised to lose weight (n = 158) 49 45 ↓4 0.9 (0.44, 1.66) 0.649 0.8 (0.43, 1.65) 0.618
Referred for support to lose
weight (n = 163)
12 14 ↓2 1.2 (0.45, 3.31) 0.680 1.0 (0.33, 2.87) 0.966
Assessed for functional ability
(n = 186)
33 35 ↑2 1.1 (0.57, 2.01) 0.835 1.1 (0.56, 2.06) 0.823
Assessed the need for walking aids
(n = 168)
36 22 ↓14 0.5 (0.24, 1.01) 0.055 0.5 (0.25, 1.10) 0.089
Assessed the need for other aids
(n = 151)
13 4 ↓9 0.3 (0.06, 1.30) 0.105 0.3 (0.06, 1.32) 0.109
Joint pain assessed by HP (n = 309) 79 80 ↑1 1.1 (0.61, 1.91) 0.804 1.1 (0.62, 1.97) 0.746
Paracetamol recommended as
first line (n = 303)
72 67 ↓5 0.8 (0.49, 1.34) 0.415 0.9 (0.53, 1.48) 0.639
Offered stronger pain killers (n = 213) 47 55 ↑8 1.4 (0.78, 2.42) 0.271 1.3 (0.75, 2.38) 0.319
Information about anti-inflammatory
medication (n = 206)
62 68 ↑6 1.4 (0.74, 2.47) 0.321 1.3 (0.70, 2.37) 0.412
Offered steroid injection (n = 206) 24 23 ↓4 1.0 (0.50, 1.87) 0.915 0.9 (0.47, 1.83) 0.837
Referred to orthopaedic surgeon
(n = 208)
51 54 ↑3 1.1 (0.64, 2.02) 0.648 1.1 (0.64, 2.04) 0.658
HP Healthcare professional, OA Osteoarthritis, OR Odds ratio, QI Quality indicator
a Individual item pass rates were calculated as the proportion of patients reporting that the QI was passed (‘Yes’) divided by the proportion of patients who were
eligible (‘Yes’ or ‘No’) for that QI item (in percentage). Pass rates range from 0 to 100, with 100 representing that all eligible patients reported pass (‘Yes’) for that
QI item
b Logistic regression model adjusted for patients’ sex and age
c Number of eligible patients for the QI item, i.e., patients that have responded ‘Yes’ or ‘No’ to that item. Patient responses ‘Not applicable’ are ignored
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In a previous study, a large proportion of PTs reported
that they would address weight by the provision of ad-
vice, but some lacked confidence in addressing weight
loss [33]. While PTs believe they have a role in address-
ing weight loss, they felt inadequately equipped to inte-
grate weight loss in their management approach [56].
Since weight reduction has been shown to significantly
reduce symptoms and improve function among those
with overweight [57, 58], future studies should investi-
gate how weight loss management for people with OA
can be improved.
To our knowledge, only one small previous study has
assessed Norwegians PTs’ practice of writing discharge
reports [37]. As PT discharge reports may provide im-
portant information for the GP to review together with
the patient, the discharge report may represent an elem-
ent in the continuity of patient information transfer. In-
formation from the PT to the GP on the effect of core
treatment and the patients’ status may lead to more ap-
propriate referrals for candidates for joint replacement
and reduce the number of inappropriate referrals. In this
study, the results showed only a small increase in the
total number of registered discharge reports and in the
number of PTs writing one or more discharge reports.
While this study was a first attempt to make interprofes-
sional communication a standard practice, ensuring the
quality of the reports should be the next step in a future
study. The results also revealed a large inter-provider
variation with the number of discharge reports regis-
tered per PT ranging from none to more than 20.
Hence, there may be other unknown barriers that hinder
the PTs in writing discharge reports. It was out of the
scope of this study to investigate other barriers or facili-
tators for writing discharge reports.
A previous study found that the content of GP referral
letters to orthopaedic surgeons often was suboptimal
[59]. This finding is supported in more recent studies on
referral letters in other medical disciplines showing that
basic items necessary for appropriate triage often were
lacking [60, 61]. According to a Cochrane Review [62],
active, local educational interventions including second-
ary care specialists are shown to impact referral practice,
Fig. 5 Patient-reported quality of osteoarthritis care: pass rates for individual OAQI v2 items during pre-implementation (n=208) and post-implementation
(n=125). All items have ‘Yes’, ‘No’, and ‘Not applicable’/‘Don’t remember’ as response options. Individual item pass rates were calculated as the proportion of
patients reporting that the QI was passed (‘Yes’) divided by the proportion of patients who were eligible (‘Yes’ or ‘No’) for that QI item (in percentage). Pass rates
range from 0 to 100, with 100 representing that all eligible patients reported pass (‘Yes’) for that QI item. OAQI v2 items wording: 1) Have you been given
information about osteoarthritis from a health professional? 2) Have you been given information about different treatment alternatives? 3) Have you been given
information about how you can self-manage the disease? 4) Have you been given information about the importance of physical activity and exercise? 5) Have
you been referred or offered a referral to a health professional who can advise you about physical activity and exercise? 6) Have you been advised to lose
weight if you are overweight? 7) Have you been referred or offered a referral to someone who can help you to lose weight, if you are overweight?8) If you
have problems with daily activities, have these problems been assessed by a health professional? 9) If you have problems with walking, has your need for a
walking aid been assessed? (e.g. stick, crutch or walker) 10) If you have problems related to other daily activities, has your need for appliances and aids been
assessed? (e.g. splints, assistive technology for cooking or personal hygiene, a special chair) 11) If you have joint pain, has it been assessed by a health
professional? 12) If you have joint pain, was paracetamol the first medication that was recommended? 13) If you have prolonged severe joint pain, which is not
relieved sufficiently by paracetamol, have you been offered stronger pain killing medications? (e.g. co-codamol, codeine, tramadol, co-proxamol, co-dydramol,
dihydrocodeine) 14) If you use anti-inflammatory medications, have you been given information about the effects and possible side-effects of this medication?
(e.g. ibuprofen (Nurofen, Brufen), diclofenac (Voltarol), naproxen (Naprosyn), celecoxib (Celebrex)) 15) If you have experienced an acute deterioration of your
symptoms, have you been given or offered a steroid injection? 16) If you are severely troubled by your osteoarthritis, and exercise and medication do not help,
have you been referred or offered a referral for an assessment for operation? (e.g. joint replacement)
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but this was not seen in the START study as there were
very few changes in the content of referral letters or in
the use of imaging modalities for OA assessment. The
multidisciplinary workshop in the START study lasted
only 1.5 h, and the information and discussion on
information in referral letters and the recommendations
for imaging may have fallen behind the other topics cov-
ered. A more intense focus in the workshop or provision
of a checklist for recommended content may have im-
proved the content of GPs’ referral letters.
Table 3 Information in GPs’ referral letters of patients to orthopaedic surgeon during pre- and post-implementation
% referrals that included
this information during
Items considered relevant to be included












Results from a clinical examination 45 51 1.2 (0.69, 2.18) 0.482
Restricted joint range of motion 35 30 0.8 (0.43, 1.48) 0.484
Joint malalignment 7 11 1.6 (0.56, 4.51) 0.379
Reduced joint stability 9 12 1.3 (0.50, 3.31) 0.602
Skin conditions, if relevant for potential surgeryb 0 3 6.0 (0.31, 118.3) 0.111
Affection of walking ability 64 53 0.6 (0.35, 1.12) 0.111
Eventual use of walking aidsb 6 6 1.0 (0.31, 3.19) 0.997
The activity level 55 53 1.0 (0.54, 1.69) 0.863
Health related quality of life 10 8 0.7 (0.27, 1.96) 0.519
The pain level 92 80 0.3 (0.11, 0.76) 0.012
The duration of pain symptoms 53 81 3.6 (1.89, 6.89) <
0.001
Eventual progression of pain 51 70 2.2 (1.22, 4.03) 0.009
Night pain 44 46 1.0 (0.60, 1.89) 0.842
Conventional radiograph (CR) being taken 57 57 1.0 (0.57, 1.81) 0.966
Magnetic resonance image (MRI) being taken 47 49 1.1 (0.61, 1.93) 0.781
The CR and MRI image(s) being recentc 84 84 1.0 (0.45, 2.13) 0.967
Used physiotherapy 22 31 1.2 (0.65, 2.33) 0.515
Used supervised exercise 14 21 1.7 (0.77, 3.62) 0.190
Having received information on the OA disease and
treatment alternativesb
2 4 1.5 (0.32, 7.37) 0.597
Having participated in an OA education programmeb 1 4 2.6 (0.40, 16.7) 0.321
Paracetamol use 41 45 1.2 (0.66, 2.10) 0.584
NSAID use 62 56 0.8 (0.45, 1,44) 0.460
Topical NSAID useb 5 2 0.5 (0.09, 2.18) 0.322
Opioid use 35 27 0.7 (0.34, 1.30) 0.253
Used non-surgical treatment alternatives for three to six
months
13 15 1.2 (0.50, 2.68) 0.725
Overweight or body mass index 12 9 0.7 (0.28, 1.88) 0.512
Having tried weight reduction, if relevantb 6 1 0.2 (0.03, 1.35) 0.101
Smoking status 22 7 0.3 (0.12, 0.72) 0.007
Having tried to stop smoking, if relevantb 7 2 0.1 (0.03, 0.41) 0.001
Comorbidity 86 76 0.5 (0.24, 1.08) 0.078
Current medications 91 86 0.7 (0.26, 1.64 0.362
HP Health professional, NSAIDS Non-Steroidal Antiinflammatory Drugs, OA Osteoarthritis, OA-QI v2 OsteoArthritis Quality Indicator questionnaire version 2, QI
Quality indicator
a To account for multiple analyses testing, a Bonferroni correction of the p-value was done (p = 0.0016)
b Analyzed using logistic regression with the Firth procedure for bias reduction in rare events
c Recent was defined as within the past 12 months
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Although a large proportion of the GP referral letters
contained information on pain, only 8% included infor-
mation on whether the patients’ quality of life was af-
fected and barely half included information from a
medical examination. Only a small proportion provided
information on whether core and supplementary treat-
ment options (e.g. medication) had already been tried.
According to the NICE guideline [4], referrals for con-
sideration of joint surgery should be restricted to people,
in which joint symptoms have a substantial impact on
their quality of life and the symptoms are refractory to
non-surgical treatment. The results in this study indicate
a large scope for improving the content of the referral
letters to facilitate timely access to orthopaedic surgeons
for consideration of joint replacement specialty care.
One strength of the START study was its alignment
to the “Joint Implementation of Guidelines for oSteo-
Arthritis in Western Europe” (JIGSAW-E) (https://
jigsaw-e.com/) which was based upon the MOSAICS
study [47] where implementation science and know-
ledge mobilisation theory (e.g. Normalisation Process
Theory, implementation theory, the Theoretical Do-
mains Framework and principles of adult learning)
was used to guide implementation and intervention
design. Another strength of this study is the use of
opinion leaders/clinical champions as moderators in
the multidisciplinary workshops and facilitators for
the implementation of OA guidelines. The involve-
ment of both primary and secondary healthcare ser-
vices in this study emphasized the importance of
continuity of patient care. The multidisciplinary work-
shops mobilized a large proportion of GPs and PTs
in the Stavanger Municipality to become updated on
OA management. The active involvement of patient
research partners in the planning phase ensured rele-
vant patient information and survey questions as well
as advices regarding the data collection and patient
confidentiality.
Some methodological limitations should be taken into
consideration when interpreting the results of the
present study. In light of recent research on sample size
and power with an interrupted time series design [63],
the small patient sample size in the START study indi-
cates that the power may have been low. The long tran-
sition period means that only persistent effects were
captured and that the effect of the intervention may have
been underestimated. Further, that 2 PTs already were
providing OA education and exercise in line with the
ActiveA management programme during pre-
implementation period, may have reduced the effect of
the implementation in the START study. It may also be
a limitation that we were unable to adjust for PT cluster-
ing of patients because the patient reports were anonym-
ous. However, as the intervention was designed to
standardize PTs’ approach and the ICC for the PT clinic
level was very low, we do not expect a high variation be-
tween individual PTs’ approach in this study. That two
PT clinics did not recruit patients post-implementation
may be due to reduced engagement. When excluding
patient responses from these two clinics in a sensitivity
analysis, the CIs became slightly more narrow, but this
did not change the conclusions. Whilst this is a prag-
matic implementation study the pre-implementation pa-
tient participant number did drop notably to the post-
implementation, which may reflect reduced engagement
among the PTs, but a selection bias related to PTs’ in
handing out the questionnaires cannot be ruled out.
Since the number of eligible OA patients is unknown,
we cannot calculate a response rate, and a patient selec-
tion bias cannot be ruled out. This also has conse-
quences for the external validity. It is also a limitation
that the registered PT discharge reports may have been
related to patients with other diagnoses than OA. Since
the GP referral letters were anonymized, it was not pos-
sible to distinguish between the referral letters from GPs
that had attended the workshop versus from GPs that
did not attend. Given that only 33% of the GPs attended
the workshop, the impact of the workshop on all referral
letters generated in the locality may have been diluted.
To get very significant clinical outcomes, a huge and
lengthy study would be required. A mixed methods ap-
proach may have provided more in-depth understanding,
but the funding available did not permit the addition of
a mixed methods quantitate and qualitative agenda.
However, we believe this study adds important know-
ledge about where the gaps currently exist.
One clinical implication of this study is that a rela-
tively small intervention can slightly shift clinicians’
provision of OA care to better align with guideline rec-
ommendations for the provision of patient information
and recommending core OA treatment modalities. Fu-
ture studies may need to be larger, include more multi-
faceted and targeted interventions, and also other
outcome measurements, including qualitative process
evaluations, in order to see effects related to other as-
pects of OA care (e.g. weight reduction advising, healthy
lifestyle changes, changes in the written communication
between health professionals, and in the use of imaging
modalities for assessment of OA). In addition, future
studies should explore how to widen health profes-
sionals’ engagement and to ensure persistence of behav-
iour change for health professionals as well as patients.
Conclusions
Implementing international OA treatment recommendations
in a primary healthcare setting is a grand endeavour, which
normally requires multidimensional interventions. In this
study implementing OA treatment recommendations in a
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primary healthcare setting through two inter-active work-
shops and implementation of a discharge report template,
OA management showed small, non-significant changes to-
wards better alignment with best practice treatment
recommendations.
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